TRJ Trajan Group Holdings Limited

ASX · AU · Healthcare · Life Science Tools · trajanscimed.com

—Mkt Cap: —P/E: —Today

Trajan Group Holdings Limited develops and manufactures analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India. The comp…

Key Statistics

Company

Market Cap—

Enterprise Value60.49M USD

Revenue (TTM)111.53M USD

Gross Profit42.87M USD

Net Income (TTM)-430.55K USD

Revenue/Share1.06 AUD

Last Price—

Fiscal Year EndJun 2026

MR QuarterJun 2026

Employees620

CountryAU

SectorHealthcare

IndustryLife Science Tools

ISINAU0000150526

Valuation

P/E (Trailing)—

P/E (Forward)6.86

PEG—

EV/EBITDA9.42

EV/Revenue0.54

P/S0.26

P/B0.42

EPS (TTM)0.00

EPS (Forward)0.04

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin38.44%

Oper. Margin2.58%

EBITDA Margin5.76%

Profit Margin-0.39%

ROE-0.63%

ROA-0.34%

Growth

Revenue Growth-9.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF167.24K USD

CapEx (TTM)2.36M USD

FCF Margin0.56%

FCF Yield—

Net Debt31.44M USD

Net Debt/EBITDA4.90

Balance Sheet

Debt/Equity0.59

Current Ratio2.06

Quick Ratio1.08

Book Value/Sh0.64 AUD

Cash/Share0.08 AUD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 AUD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)0.5167 AUD

Target Range0.4500 AUD – 0.6000 AUD

# Analysts3

Ownership

Shares Out.152.86M

Float62.11M

Insiders59.54%

Institutions21.74%

Technical

SMA 500.2090 AUD

SMA 2000.3665 AUD

Beta0.44

S&P 52W Chg16.44%

Avg Vol (30d)—

Avg Vol (10d)96.67K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

TRJ Trajan Group Holdings Limited

Industry Peers

Key Statistics